Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	VCAN PKD1 CD44 FREM1	6.27e-04	97	75	4	3.10.100.10
Domain	C-type_lectin-like/link	VCAN PKD1 CD44 FREM1	6.77e-04	99	75	4	IPR016186
Domain	CTDL_fold	VCAN PKD1 CD44 FREM1	9.05e-04	107	75	4	IPR016187
Domain	LINK	VCAN CD44	1.21e-03	13	75	2	SM00445
Domain	Link_dom	VCAN CD44	1.21e-03	13	75	2	IPR000538
Domain	Xlink	VCAN CD44	1.21e-03	13	75	2	PF00193
Domain	LINK_1	VCAN CD44	1.21e-03	13	75	2	PS01241
Domain	LINK_2	VCAN CD44	1.21e-03	13	75	2	PS50963
Domain	Cadherin	FAT1 DSC2 PCDHA12 FREM1	1.30e-03	118	75	4	IPR002126
Domain	RhoGAP	ABR ARHGAP23 ARHGAP21	1.98e-03	62	75	3	SM00324
Domain	RhoGAP	ABR ARHGAP23 ARHGAP21	2.08e-03	63	75	3	PF00620
Domain	RHOGAP	ABR ARHGAP23 ARHGAP21	2.17e-03	64	75	3	PS50238
Domain	RhoGAP_dom	ABR ARHGAP23 ARHGAP21	2.17e-03	64	75	3	IPR000198
Domain	-	ABR ARHGAP23 ARHGAP21	2.17e-03	64	75	3	1.10.555.10
Domain	C_TYPE_LECTIN_1	VCAN PKD1 FREM1	4.09e-03	80	75	3	PS00615
Domain	Znf_RING_CS	TRIM72 RC3H1 CUL9 UBOX5	4.20e-03	163	75	4	IPR017907
Domain	Lectin_C	VCAN PKD1 FREM1	4.69e-03	84	75	3	PF00059
Domain	CLECT	VCAN PKD1 FREM1	4.69e-03	84	75	3	SM00034
Domain	C_TYPE_LECTIN_2	VCAN PKD1 FREM1	4.85e-03	85	75	3	PS50041
Domain	SANT_dom	NCOR1 TADA2A	4.86e-03	26	75	2	IPR017884
Domain	C-type_lectin-like	VCAN PKD1 FREM1	5.01e-03	86	75	3	IPR001304
Domain	Rho_GTPase_activation_prot	ABR ARHGAP23 ARHGAP21	5.34e-03	88	75	3	IPR008936
Domain	SANT	NCOR1 TADA2A	5.62e-03	28	75	2	PS51293
Domain	Galactose-bd-like	LAMA5 CUL9 UBOX5	6.42e-03	94	75	3	IPR008979
Domain	EGF_Ca-bd_CS	FAT1 CCBE1 VCAN	7.00e-03	97	75	3	IPR018097
Domain	EGF_CA	FAT1 CCBE1 VCAN	7.40e-03	99	75	3	PS01187
Domain	ASX_HYDROXYL	FAT1 CCBE1 VCAN	7.61e-03	100	75	3	PS00010
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	NPC1 NCOR1 FAT1 TNRC18 ABR NAPRT PKD1 LAMA5 CUL9 WDR90 ARHGAP21 DYNC1H1 MADD	1.37e-06	1105	80	13	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOR1 FRY PPP3CB ABR DLGAP4 TBC1D7 YLPM1 GRIA2 QSER1 SSH2 ARHGAP21 DYNC1H1	2.03e-06	963	80	12	28671696
Pubmed	The role of the amino-terminal domain in the interaction of unliganded peroxisome proliferator-activated receptor gamma-2 with nuclear receptor co-repressor.	NCOR1 PPARG	5.23e-06	2	80	2	20587609
Pubmed	CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma.	VCAN CD44	5.23e-06	2	80	2	17957481
Pubmed	Deletion of CD44 promotes adipogenesis by regulating PPARγ and cell cycle-related pathways.	CD44 PPARG	5.23e-06	2	80	2	38692289
Pubmed	Versican and CD44 in in vitro valvular interstitial cell injury and repair.	VCAN CD44	5.23e-06	2	80	2	21546273
Pubmed	Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.	VCAN CD44	5.23e-06	2	80	2	21136024
Pubmed	Spatial, a new nuclear factor tightly regulated during mouse spermatogenesis.	NPC1 TBATA	5.23e-06	2	80	2	12711538
Pubmed	A direct functional link between the multi-PDZ domain protein GRIP1 and the Fraser syndrome protein Fras1.	LAMA5 GRIA2 FREM1	9.33e-06	18	80	3	14730302
Pubmed	Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ.	NCOR1 PPARG	1.57e-05	3	80	2	30575522
Pubmed	Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity.	NCOR1 PPARG	1.57e-05	3	80	2	22078880
Pubmed	V3 versican isoform alters the behavior of human melanoma cells by interfering with CD44/ErbB-dependent signaling.	VCAN CD44	1.57e-05	3	80	2	21078678
Pubmed	A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells.	NCOR1 PPARG	1.57e-05	3	80	2	22349439
Pubmed	RNF20 Functions as a Transcriptional Coactivator for PPARγ by Promoting NCoR1 Degradation in Adipocytes.	NCOR1 PPARG	1.57e-05	3	80	2	31604693
Pubmed	Hyaluronan and its binding proteins during cervical ripening and parturition: dynamic changes in size, distribution and temporal sequence.	VCAN CD44	1.57e-05	3	80	2	18353623
Pubmed	Structural basis for iloprost as a dual peroxisome proliferator-activated receptor alpha/delta agonist.	NCOR1 PPARG	1.57e-05	3	80	2	21775429
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	NPC1 DHX15 FAT1 CD44 LPCAT4 LAMA5 TMEM131 UST ATP2B1 ARHGAP21 ALG1 MADD	1.88e-05	1201	80	12	35696571
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NCOR1 MFNG TNRC18 YLPM1 DACT2 LPCAT4 GRIA2 CFAP74 ZFC3H1 MINDY2 ATP2B1 ARHGAP21 TOP2A	2.40e-05	1442	80	13	35575683
Pubmed	The ubiquitin ligase Siah2 regulates PPARγ activity in adipocytes.	NCOR1 PPARG	3.13e-05	4	80	2	22294748
Pubmed	A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.	NCOR1 PPARG	3.13e-05	4	80	2	19147680
Pubmed	KLF7 Alleviates Atherosclerotic Lesions and Inhibits Glucose Metabolic Reprogramming in Macrophages by Regulating HDAC4/miR-148b-3p/NCOR1.	NCOR1 KLF7	3.13e-05	4	80	2	35439761
Pubmed	Sumoylation of PPARγ contributes to vascular endothelium insulin resistance through stabilizing the PPARγ-NcoR complex.	NCOR1 PPARG	3.13e-05	4	80	2	30982983
Pubmed	A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.	NCOR1 PPARG	3.13e-05	4	80	2	10339548
Pubmed	Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts.	VCAN CD44	3.13e-05	4	80	2	19164294
Pubmed	Regulation of small ubiquitin-like modifier-1, nuclear receptor coreceptor, histone deacetylase 3, and peroxisome proliferator-activated receptor-γ in human adipose tissue.	NCOR1 PPARG	3.13e-05	4	80	2	22651256
Pubmed	Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44.	VCAN CD44	3.13e-05	4	80	2	10950950
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NPC1 FRY PPP3CB YLPM1 PKD1 CUL9 UBA3 TMEM131 ZFC3H1 ARHGAP21 DYNC1H1 MADD	3.64e-05	1285	80	12	35914814
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	NPC1 DHX15 MAPKAP1 NCOR1 ZNF106 FAT1 DDX59 NAPRT LAMA5 STARD7 DYNC1H1 ALG1	3.98e-05	1297	80	12	33545068
Pubmed	The phosphorylation status of T522 modulates tissue-specific functions of SIRT1 in energy metabolism in mice.	NCOR1 CD44 PPARG	4.10e-05	29	80	3	28364022
Pubmed	Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.	NCOR1 PPARG	5.20e-05	5	80	2	23703729
Pubmed	Tbata modulates thymic stromal cell proliferation and thymus function.	TBATA UBA3	5.20e-05	5	80	2	20937703
Pubmed	Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma.	NCOR1 PPARG	5.20e-05	5	80	2	15175761
Pubmed	Kif3a deficiency reverses the skeletal abnormalities in Pkd1 deficient mice by restoring the balance between osteogenesis and adipogenesis.	PKD1 PPARG	5.20e-05	5	80	2	21151991
Pubmed	A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro.	NCOR1 PPARG	7.79e-05	6	80	2	16373399
Pubmed	Immunosurveillance of the liver by intravascular effector CD8(+) T cells.	CD44 TPH1	7.79e-05	6	80	2	25892224
Pubmed	The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis.	NCOR1 PPARG	7.79e-05	6	80	2	17468099
Pubmed	Sumoylation of peroxisome proliferator-activated receptor gamma by apoptotic cells prevents lipopolysaccharide-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines.	NCOR1 PPARG	7.79e-05	6	80	2	18832723
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	FAT1 TNRC18 ARHGAP23 ASF1B NAPRT VCAN DLGAP4 PKD1 STARD7 SEMA3G FREM1	1.04e-04	1215	80	11	15146197
Pubmed	SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-delta.	NCOR1 PPARG	1.09e-04	7	80	2	18500350
Pubmed	Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.	NCOR1 PPARG	1.09e-04	7	80	2	11903058
Pubmed	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	NCOR1 PPARG	1.45e-04	8	80	2	16127449
Pubmed	Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC.	CD44 PPARG	1.45e-04	8	80	2	23736812
Pubmed	Severe acute respiratory syndrome coronavirus protein 6 mediates ubiquitin-dependent proteosomal degradation of N-Myc (and STAT) interactor.	FRY PKD1	1.45e-04	8	80	2	25907116
Pubmed	Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.	NCOR1 PPARG	1.45e-04	8	80	2	9121466
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAPKAP1 ZNF106 DSC2 KIF26B SSH2 MAPK4 ATP2B1 ARHGAP21 MADD	1.62e-04	861	80	9	36931259
Pubmed	Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors.	NCOR1 PPARG	1.86e-04	9	80	2	11891224
Pubmed	Mice lacking the giant protocadherin mFAT1 exhibit renal slit junction abnormalities and a partially penetrant cyclopia and anophthalmia phenotype.	FAT1 DSC2	2.32e-04	10	80	2	12724416
Pubmed	Natural helix 9 mutants of PPARγ differently affect its transcriptional activity.	NCOR1 PPARG	2.32e-04	10	80	2	30595551
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	DHX15 ABR RC3H1 YLPM1 CD44 TMEM131 ZFC3H1 EIF2A	2.63e-04	724	80	8	36232890
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	DDX59 ABR NAPRT PKD1 CD44 WDR90 EIF2A LDLRAD4 MADD	2.75e-04	925	80	9	28986522
Pubmed	Versican facilitates chondrocyte differentiation and regulates joint morphogenesis.	VCAN CD44	2.84e-04	11	80	2	20404343
Pubmed	Developmental basis for filamin-A-associated myxomatous mitral valve disease.	VCAN TPH1	2.84e-04	11	80	2	22843703
Pubmed	Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.	NCOR1 PPARG	2.84e-04	11	80	2	15681609
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	PPP3CB ABR DLGAP4 GRIA2 DYNC1H1	2.91e-04	251	80	5	27507650
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	MAPKAP1 FAT1 PPP3CB DSC2 CD44 ATP2B1 ARHGAP21	3.43e-04	569	80	7	30639242
Pubmed	Transgenic mouse proteomics identifies new 14-3-3-associated proteins involved in cytoskeletal rearrangements and cell signaling.	PPP3CB ATP2B1 DYNC1H1 MADD	3.78e-04	147	80	4	16959763
Pubmed	Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.	TRIM72 AKTIP UBA3 UBOX5	3.97e-04	149	80	4	19549727
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	DSC2 ARHGAP23 CD44 LAMA5 SEMA3G DYNC1H1	4.08e-04	417	80	6	19199708
Pubmed	Human transcription factor protein interaction networks.	NCOR1 FAT1 RC3H1 YLPM1 CUL9 MRPL28 TADA2A QSER1 HAL PPARG DYNC1H1	4.21e-04	1429	80	11	35140242
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	DHX15 ARHGAP23 AJM1 VCAN DLGAP4 GRIA2 SSH2 ATP2B1 ARHGAP21 DYNC1H1 MADD	4.26e-04	1431	80	11	37142655
Pubmed	Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex.	TNRC18 TOP2A DYNC1H1	4.41e-04	64	80	3	22865885
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	DHX15 FAT1 DSC2 ARHGAP23 AJM1 CD44 LAMA5 MRPL28 HAL ATP2B1 ALG1	4.79e-04	1451	80	11	30550785
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NCOR1 TNRC18 YLPM1 WDR90 LDLRAD4 DYNC1H1	4.79e-04	430	80	6	35044719
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	ARHGAP23 VCAN DLGAP4 GRIA2 ATP2B1 ARHGAP21	4.79e-04	430	80	6	32581705
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	ARHGAP23 AJM1 ARHGAP21	5.05e-04	67	80	3	29254152
Pubmed	IKAP localizes to membrane ruffles with filamin A and regulates actin cytoskeleton organization and cell migration.	ELP2 DYNC1H1	5.38e-04	15	80	2	18303054
Pubmed	Ontogeny of stromal organizer cells during lymph node development.	CD44 LAMA5	6.14e-04	16	80	2	20237296
Pubmed	Expression of aldehyde dehydrogenase family 1, member A3 in glycogen trophoblast cells of the murine placenta.	CYP26A1 PPARG	6.14e-04	16	80	2	25577283
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NPC1 NCOR1 RC3H1 YLPM1 UBA3 QSER1	6.59e-04	457	80	6	32344865
Pubmed	Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16.	CCDC78 MRPL28 WDR90	6.75e-04	74	80	3	11157797
Pubmed	LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.	DHX15 FRY FAT1 PPP3CB ABR CUL9 EIF2A	6.82e-04	639	80	7	23443559
Pubmed	Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals.	CYP26A1 CD44	6.95e-04	17	80	2	35079138
Pubmed	Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits.	DACT2 PPARG	6.95e-04	17	80	2	23754948
Pubmed	Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.	EIF2A ALG1	6.95e-04	17	80	2	32938586
Pubmed	Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population.	NPC1 PPARG MADD	7.02e-04	75	80	3	20571754
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	MAPKAP1 ARHGAP23 ELP2 QSER1 ARHGAP21 ALG1 MADD	7.53e-04	650	80	7	38777146
Pubmed	RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation.	DHX15 TOP2A	7.81e-04	18	80	2	27558965
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	DHX15 PPARG TOP2A	8.48e-04	80	80	3	35803934
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NPC1 PPP3CB VCAN TMEM131 QSER1 UBOX5 ATP2B1 ARHGAP21 MADD	8.58e-04	1084	80	9	11544199
Pubmed	The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.	ASF1B TOP2A	8.71e-04	19	80	2	20504901
Pubmed	Genome-wide association study of blood pressure and hypertension.	ATP2B1 LDLRAD4	8.71e-04	19	80	2	19430479
Pubmed	Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.	CD44 CLNK	8.71e-04	19	80	2	22561518
Pubmed	Repression by PRDM13 is critical for generating precision in neuronal identity.	MFNG CCBE1	9.66e-04	20	80	2	28850031
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOR1 PPARG	9.66e-04	20	80	2	11877444
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ABR DLGAP4 PKD1 PCDHA12 CUL9	9.89e-04	329	80	5	17474147
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	FAT1 TNRC18 UST TOP2A DYNC1H1	1.03e-03	332	80	5	37433992
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOR1 PPARG	1.07e-03	21	80	2	19596656
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	LAMA5 FREM1	1.07e-03	21	80	2	27856617
Pubmed	Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis.	NCOR1 CYP26A1	1.07e-03	21	80	2	30254164
Pubmed	Genome-wide, large-scale production of mutant mice by ENU mutagenesis.	TDRD7 DYNC1H1	1.17e-03	22	80	2	10932192
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	DHX15 ABR DSC2 EIF2A ATP2B1 ARHGAP21 DYNC1H1	1.24e-03	708	80	7	39231216
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	NPC1 YLPM1 ZFC3H1 ATP2B1	1.24e-03	202	80	4	24639526
Pubmed	The interactome of CLUH reveals its association to SPAG5 and its co-translational proximity to mitochondrial proteins.	ZNF106 EIF2A TOP2A DYNC1H1	1.26e-03	203	80	4	35012549
Pubmed	Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells.	CD44 PPARG	1.28e-03	23	80	2	27974211
Pubmed	Interaction network of human early embryonic transcription factors.	NCOR1 TNRC18 TADA2A QSER1 TOP2A	1.32e-03	351	80	5	38297188
Pubmed	A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.	CUL9 DYNC1H1	1.40e-03	24	80	2	33705438
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	RC3H1 YLPM1 ATP2B1 TOP2A DYNC1H1	1.44e-03	358	80	5	32460013
Pubmed	Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition.	DSC2 KLF7	1.51e-03	25	80	2	17130451
Pubmed	Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.	NPC1 DLGAP4 UBA3 TOP2A DYNC1H1 MADD	1.52e-03	538	80	6	28524877
Pubmed	Adamts18 modulates the development of the aortic arch and common carotid artery.	VCAN LAMA5	1.64e-03	26	80	2	34189436
Cytoband	16p13.3	CCDC78 PKD1 MRPL28 WDR90 ALG1	7.07e-05	244	80	5	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr16p13	CCDC78 PKD1 MRPL28 WDR90 ALG1	9.13e-04	426	80	5	chr16p13
Cytoband	4q32.1	GRIA2 GASK1B	9.48e-04	26	80	2	4q32.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4q32	GRIA2 TKTL2 GASK1B	1.24e-03	120	80	3	chr4q32
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	VCAN PKD1 FREM1	2.91e-04	41	57	3	1298
Coexpression	GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP	NCOR1 FRY ABR ATP2B1 TKTL2 ARHGAP21	9.40e-06	159	80	6	M8814
Coexpression	GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN	TDRD7 ABR KLF7 RC3H1 DLGAP4 CD44	1.38e-05	170	80	6	M6855
Coexpression	GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP	FAT1 PPP3CB CYP26A1 LAMA5 STARD7 MAPK4	3.35e-05	199	80	6	M8164
Coexpression	GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP	FRY KLF7 VCAN CD44 HAL GASK1B	3.44e-05	200	80	6	M4966
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	FAT1 KLF7 POLE2 LPCAT4 ZFC3H1 ATP2B1 TOP2A	3.73e-05	300	80	7	M8702
Coexpression	MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD	TNRC18 KLF7 KIF26B VCAN CFAP74	4.11e-05	125	80	5	M38988
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NPC1 CCBE1 PPARG CLNK UST FREM1	8.58e-07	179	80	6	e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf
ToppCell	severe-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DSC2 ARRDC4 VCAN PPARG ATP2B1 GASK1B	1.64e-06	200	80	6	db7046741706376682d164c385c4701aebefc2e6
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CCDC192 TRIM72 CLNK FREM1	5.78e-06	65	80	4	4382d56d5f71c7acfe35f84db7257aba2a7dd36a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	CCDC192 TRIM72 CLNK FREM1	5.78e-06	65	80	4	05b712f83d88e864747cd0229a39aca17321e0f8
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ASF1B VCAN TBC1D7 HAL TOP2A	1.43e-05	171	80	5	6e7ade1d14a3ec4c566476aac3eb509bd2661e39
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCBE1 AJM1 CD44 SSH2 MADD	1.47e-05	172	80	5	574ebdf36e45222bcd907cd2c2ee7ff50ed4573a
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCBE1 AJM1 CD44 SSH2 MADD	1.47e-05	172	80	5	1627fa7035b0e0bbc82a1c0f000d8231254c680a
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B VCAN CD44 HAL ATP2B1	1.60e-05	175	80	5	cd42020fe57afeaadfbd3ef6d7375e66d71e9669
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-nan\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC2 CD44 STARD7 PPARG ATP2B1	1.64e-05	176	80	5	1dd54bfaa58541de51e5a8328651d390833bd480
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CCBE1 PPARG CLNK UST FREM1	1.88e-05	181	80	5	30729f0364f719c044712a51453e22dc2c1a232b
ToppCell	COVID-19-kidney-Podocyte\|kidney / Disease (COVID-19 only), tissue and cell type	FRY KLF7 ARRDC4 CCBE1 SEMA3G	1.98e-05	183	80	5	fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FRY KLF7 ARHGAP23 ARRDC4 CCBE1	2.09e-05	185	80	5	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAPKAP1 FRY DDX59 ARHGAP23 RC3H1	2.20e-05	187	80	5	3699d5e71d779da922920aa3160895db187bf81b
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAPKAP1 FRY DDX59 ARHGAP23 RC3H1	2.20e-05	187	80	5	033ba52c0c2f9978784947098fa697368ae44834
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175\|Adult / Lineage, Cell type, age group and donor	MAPKAP1 ABR ARRDC4 CD44 PPARG	2.49e-05	192	80	5	733491e932350e3c216a626cc49c3cd3fe970a82
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FAT1 CCBE1 GRIA2 UST FREM1	2.55e-05	193	80	5	e2b455387d1de7812305200a2041a0f4759a6f54
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	SPATA6 VCAN UST GASK1B FREM1	2.68e-05	195	80	5	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	Control-Treg\|Control / Disease condition and Cell class	CD44 SEMA3G CLNK ATP2B1 LDLRAD4	2.68e-05	195	80	5	bbe9789eb2c17f43de55b2e6d01d1093c64dc666
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	SPATA6 VCAN SSH2 UST GASK1B	2.68e-05	195	80	5	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)\|Adult / Lineage, Cell type, age group and donor	ABR ARRDC4 VCAN PPARG ATP2B1	2.68e-05	195	80	5	55e25f702af19146a161861cfd15f40bbda1dc35
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B CCBE1 VCAN UST FREM1	2.75e-05	196	80	5	a12dd986df65c36f248cf10815c3b8b6238613b0
ToppCell	droplet-Tongue-TONGUE\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC2 DACT2 LPCAT4 MINDY2 ATP2B1	2.75e-05	196	80	5	44a30b1a5f3d8c845e5f3bd17d8102a7449f555b
ToppCell	droplet-Tongue-TONGUE-1m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC2 DACT2 LPCAT4 MINDY2 ATP2B1	2.75e-05	196	80	5	9935bdb10789e8cfc922dca526ca3bf8317fe270
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSC2 DACT2 LPCAT4 MINDY2 ATP2B1	2.75e-05	196	80	5	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B CCBE1 VCAN UST FREM1	2.75e-05	196	80	5	3e6803587d8566fd08cb8b290be3b6461743d79c
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DSC2 ARRDC4 NAPRT VCAN PPARG	2.82e-05	197	80	5	d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B CCBE1 VCAN UST FREM1	2.82e-05	197	80	5	6d027119a5f7ca2aac1b10837e43f9a2bb54db85
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DSC2 ARRDC4 NAPRT VCAN PPARG	2.82e-05	197	80	5	33f2fe101ae5744eea3915add37e60aa398bb97f
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DSC2 ARRDC4 NAPRT VCAN PPARG	2.82e-05	197	80	5	5e9a3932ae5147a3d73dc70f1545926a692930ed
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B CCBE1 VCAN UST FREM1	2.82e-05	197	80	5	b349f8e96d61a4c296af64711e11fc44459a9413
ToppCell	Severe_COVID-19-Myeloid-TRAM2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DSC2 ARRDC4 NAPRT VCAN PPARG	2.82e-05	197	80	5	8a126cfe1529f3d75a806aa492743314a8a43ef9
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM2-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DSC2 ARRDC4 NAPRT VCAN PPARG	2.82e-05	197	80	5	9262785807faeb32417fad7ef202405053e453e2
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KIF26B CCBE1 VCAN UST FREM1	2.82e-05	197	80	5	c2e390653d5dee7e731c1840cfdab41987dede9b
ToppCell	Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231\|Adult / Lineage, Cell type, age group and donor	ABR ARRDC4 VCAN PPARG ATP2B1	2.89e-05	198	80	5	79a415e19cedde13a88f5043d71557363f102322
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	ABR VCAN PPARG ATP2B1 LDLRAD4	2.89e-05	198	80	5	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Sepsis-URO\|Sepsis / Disease, condition lineage and cell class	KLF7 VCAN SSH2 PPARG GASK1B	2.96e-05	199	80	5	8e6dac82d1d0e759cd567f9c95b70cb4801d7caf
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT1 VCAN TMEM131 MAPK4 TOP2A	2.96e-05	199	80	5	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	FRY ABR VCAN ATP2B1 ARHGAP21	3.03e-05	200	80	5	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CCBE1 VCAN CYP26A1 UST GASK1B	3.03e-05	200	80	5	d31e26387d879ee30731c497cea6aaf4746e40d9
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_ALM_Macc1_Lrg1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CCBE1 DACT2 MAPK4 PPARG	1.25e-04	142	80	4	d08e1880425d285c4433014fe0242ac7ff7734af
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	DACT2 PCDHA12 CLNK ATP2B1	1.39e-04	146	80	4	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ASF1B POLE2 VCAN UST	1.54e-04	150	80	4	70ac8ae4b1683fb17278a8e4606f2fa0b94988c0
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CYP26A1 HAL TKTL2	1.56e-04	58	80	3	12fecf2fee0dbf5290a7b2389b2cdb0ae00a02b4
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))-\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CYP26A1 HAL TKTL2	1.56e-04	58	80	3	856be27020dbfa7c1f57bd78840c60f52ca68ed8
ToppCell	Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))--\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CYP26A1 HAL TKTL2	1.56e-04	58	80	3	e0cd231f33f5650db4991157cfe4867ccfc774b9
ToppCell	facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR LPCAT4 UBOX5 UST	1.62e-04	152	80	4	87a7116d0064a6051bdf28ce1e48bfc168273e66
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW08-Neuronal\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	DLGAP4 GRIA2 DYNC1H1	1.64e-04	59	80	3	74590437b1d9a2a8fe56d79b2e66803528b81298
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B VCAN HAL GASK1B	2.02e-04	161	80	4	3a5f2877e3b29463a3a6da05009b0ab8747b4c47
ToppCell	367C-Fibroblasts-Fibroblast-F\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DACT2 GRIA2 SEMA3G TOP2A	2.02e-04	161	80	4	c61283c301a87bb802f6f8ce79c26067032dd7d9
ToppCell	367C-Fibroblasts-Fibroblast-F-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DACT2 GRIA2 SEMA3G TOP2A	2.02e-04	161	80	4	9864d8b0929dacf4be7a4e97d2527ac3120ea264
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-7\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	CYP26A1 STARD7 UST ATP2B1	2.17e-04	164	80	4	81c41e1b5535b7969bcf6fa2456f828e8e8e2ff7
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CCBE1 CYP26A1 UST GASK1B	2.22e-04	165	80	4	fee7f2f8d0e25c0d067adc73f8913721bd709a3e
ToppCell	CV-Mild-3\|Mild / Virus stimulation, Condition and Cluster	AJM1 WDR90 LDLRAD4 TOP2A	2.27e-04	166	80	4	5599f90fc0e15a3670b03187085eba91228390a2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CCBE1 CYP26A1 UST GASK1B	2.32e-04	167	80	4	a6ff7a3d9b80839c0efa91658836812e868561fa
ToppCell	facs-Spleen-nan-3m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LPCAT4 CLNK UST TOP2A	2.38e-04	168	80	4	74dc46738f1d0a448df6c9b8288b515d92697792
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	KIF26B AJM1 QSER1 MINDY2	2.38e-04	168	80	4	c70bf73bb800e4722cedc35bbc17ea3113d1012d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CCBE1 VCAN CYP26A1 GASK1B	2.43e-04	169	80	4	1c9e54e7b14eb99996590fb93b257cf881a9f184
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CCBE1 CYP26A1 UST GASK1B	2.43e-04	169	80	4	0c341f91dc21aaf92bead18d59684d11510502ce
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY ARRDC4 CCBE1 SEMA3G	2.49e-04	170	80	4	60bbd738c12e64e483485586c30057304884f5a6
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABR NAPRT CYP26A1 TOP2A	2.49e-04	170	80	4	7534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B VCAN HAL ATP2B1	2.49e-04	170	80	4	46a81d505de845cc59f80594fce338f7fdb9250f
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B VCAN HAL ATP2B1	2.49e-04	170	80	4	1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a
ToppCell	3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIF26B VCAN HAL ATP2B1	2.49e-04	170	80	4	830646815410c47e9bca8c9bae75dfc45c9c9b33
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	TDRD7 MFNG CUL9 GASK1B	2.60e-04	172	80	4	3b9be685fcd1634498a603b692f5ac6ddd0de176
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ASF1B POLE2 WDR90 TOP2A	2.60e-04	172	80	4	35c20de4db47dbf31c857d23c7a25cd7f95c085c
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Tall_Cell\|TCGA-Thryoid / Sample_Type by Project: Shred V9	NPC1 DSC2 VCAN CYP26A1	2.66e-04	173	80	4	2e9dc137f3675eee07f941eb4cfcaf24a83ab0fb
ToppCell	15-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	FAT1 CYP26A1 TOP2A MADD	2.72e-04	174	80	4	fa0681e91724b9a51ee28b214ea5aa14e62ba1a3
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABR GRIA2 SEMA3G PPARG	2.72e-04	174	80	4	3d4c05ea5719ca65e85d1f15198453034791087c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCBE1 CLNK UST FREM1	2.72e-04	174	80	4	5f4436863a40f8bca46e2989bca66c02b6be88d4
ToppCell	droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC192 LPCAT4 SSH2 PPARG	2.78e-04	175	80	4	c8cfe0ac0c1ac447c626a623cc49692a0b177a1c
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC192 LPCAT4 SSH2 PPARG	2.78e-04	175	80	4	61fbd8f685d3daad46449e4c0386a38886496566
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CCBE1 CLNK UST FREM1	2.78e-04	175	80	4	77c16e615c0fb9c83f29d7e0a547be72635fac81
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCBE1 CLNK UST FREM1	2.78e-04	175	80	4	98947a226b5a2ac7091ff9d34243ea7736add973
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	GRIA2 CLNK FREM1 TPH1	2.78e-04	175	80	4	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	GRIA2 CLNK FREM1 TPH1	2.78e-04	175	80	4	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CCBE1 CLNK UST FREM1	2.84e-04	176	80	4	25ebc8716aa44e44fce577701e3e82c6745a75ab
ToppCell	droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCBE1 AJM1 CD44 MADD	2.84e-04	176	80	4	8e89471f838ea81235256cc2470f1c12c9b75f8a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY KLF7 CCBE1 SEMA3G	2.90e-04	177	80	4	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	ASK440-Immune-Mast_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CD44 CLNK FREM1 TPH1	2.96e-04	178	80	4	dcefc4afca3a40d1bd44722e66bca6b45a6c6c55
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY KLF7 CCBE1 SEMA3G	2.96e-04	178	80	4	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MFNG GRIA2 SEMA3G GASK1B	2.96e-04	178	80	4	c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY KLF7 ARHGAP23 CCBE1	3.03e-04	179	80	4	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	368C-Lymphocytic-ILC-ILC-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AKTIP ABR MINDY2 MADD	3.09e-04	180	80	4	eb5a57604c7f2ad256c300085dbf5069d0ae1ad0
ToppCell	368C-Lymphocytic-ILC\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	AKTIP ABR MINDY2 MADD	3.09e-04	180	80	4	ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c
ToppCell	(2)_NK/T-(230)_CD4+/CD25+_Reg_T_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	ARHGAP23 CD44 CUL9 SEMA3G	3.16e-04	181	80	4	ad14c7111d4fb924afd233cb114447f195373a7c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRY PPARG FREM1 INPP5J	3.16e-04	181	80	4	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRY FAT1 KIF26B VCAN	3.16e-04	181	80	4	5f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCell	356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|356C / Donor, Lineage, Cell class and subclass (all cells)	ASF1B CYP26A1 TOP2A FREM1	3.16e-04	181	80	4	be4f35c9eb5b3083acb2264128f095fac1f3da45
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FRY FAT1 KIF26B VCAN	3.16e-04	181	80	4	c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCBE1 CD44 PPARG TOP2A	3.22e-04	182	80	4	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY ARRDC4 CCBE1 SEMA3G	3.22e-04	182	80	4	cde8fa4f42d25545abaa9ee885b4b1e24a5a8e08
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRY KLF7 ARHGAP23 CCBE1	3.29e-04	183	80	4	848fc6dd129150897ee339343e83c645b6e779eb
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AKTIP FRY KIF26B PKD1	3.29e-04	183	80	4	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	Immune_cells-large_pre-B.\|World / Lineage and Cell class	ASF1B GRIA2 LDLRAD4 TOP2A	3.29e-04	183	80	4	81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ASF1B WDR90 MAPK4 TOP2A	3.29e-04	183	80	4	6c1d7ce60e67bf1df364a4e177c351e7313eb41f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT1 KIF26B CCBE1 FREM1	3.36e-04	184	80	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	IIF-Lymphocyte-T_NK-T_NK_proliferative\|IIF / Disease, Lineage and Cell Type	ASF1B POLE2 SEMA3G TOP2A	3.36e-04	184	80	4	ab8b45ce40e8c5f66e5c23332a591b4f9cba4ce1
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC78 MAPK4 PPARG FREM1	3.36e-04	184	80	4	6b0c110d8930df99043c3b99cf4d873985126960
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC78 MAPK4 PPARG FREM1	3.36e-04	184	80	4	35928fc5f7bbf8c7b09181a2bd27e22dff42ec16
ToppCell	T_cells-Resident_memory_CD8+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	AKTIP CD44 CLNK LDLRAD4	3.36e-04	184	80	4	e04cabff33a8e36967622ec3e5b37b89afa7e148
Disease	Intellectual Disability	FRY KLF7 CCBE1 TBC1D7 GRIA2 ELP2 EIF2A DYNC1H1	2.66e-05	447	79	8	C3714756
Disease	Hydrops Fetalis, Non-Immune	CCBE1 ALG1	1.47e-04	7	79	2	C0455988
Disease	Polycystic kidney disease, type 2	PKD1 PPARG	1.47e-04	7	79	2	C2751306
Disease	cortical thickness	ZNF106 ARRDC4 VCAN YLPM1 PKD1 CUL9 TMEM131 QSER1 SSH2 MINDY2 ARHGAP21	1.81e-04	1113	79	11	EFO_0004840
Disease	Polycystic Kidney, Type 1 Autosomal Dominant Disease	PKD1 PPARG	1.96e-04	8	79	2	C0887850
Disease	thyroid stimulating hormone measurement	DHX15 FRY SPATA6 CCBE1 DACT2 LDLRAD4	2.33e-04	323	79	6	EFO_0004748
Disease	Malignant neoplasm of salivary gland	FAT1 VCAN TOP2A	2.42e-04	45	79	3	C0220636
Disease	Polycystic Kidney, Autosomal Dominant	PKD1 PPARG	2.52e-04	9	79	2	C0085413
Disease	Salivary Gland Neoplasms	FAT1 VCAN TOP2A	2.75e-04	47	79	3	C0036095
Disease	intracranial aneurysm (is_implicated_in)	VCAN PKD1	4.59e-04	12	79	2	DOID:10941 (is_implicated_in)
Disease	Mental Retardation, Psychosocial	FRY CCBE1 ELP2 DYNC1H1	5.39e-04	139	79	4	C0025363
Disease	Profound Mental Retardation	FRY CCBE1 ELP2 DYNC1H1	5.39e-04	139	79	4	C0020796
Disease	Mental deficiency	FRY CCBE1 ELP2 DYNC1H1	5.39e-04	139	79	4	C0917816
Disease	Malignant neoplasm of liver	NCOR1 DACT2 PPARG TOP2A	5.84e-04	142	79	4	C0345904
Disease	Liver neoplasms	NCOR1 DACT2 PPARG TOP2A	5.84e-04	142	79	4	C0023903
Disease	thalamus volume change measurement	FAT1 KIF26B	6.31e-04	14	79	2	EFO_0021496
Disease	polycystic kidney disease (implicated_via_orthology)	PKD1 PPARG	6.31e-04	14	79	2	DOID:0080322 (implicated_via_orthology)
Disease	Barrett Epithelium	CYP26A1 PPARG	8.29e-04	16	79	2	C1258085
Disease	nervousness	YLPM1 MADD	8.29e-04	16	79	2	NCIT_C74532
Disease	Polyposis, Adenomatous Intestinal	CYP26A1 CD44	8.29e-04	16	79	2	C2713442
Disease	Familial Intestinal Polyposis	CYP26A1 CD44	8.29e-04	16	79	2	C2713443
Disease	Barrett Esophagus	CYP26A1 PPARG	8.29e-04	16	79	2	C0004763
Disease	cholesterol in very large HDL measurement	CYP26A1 PPARG MADD	8.52e-04	69	79	3	EFO_0022229
Disease	cortical surface area measurement	NCOR1 ZNF106 ABR ARRDC4 KIF26B VCAN PKD1 CUL9 QSER1 SSH2 ARHGAP21	8.89e-04	1345	79	11	EFO_0010736
Disease	Endometrioma	NCOR1 VCAN CYP26A1 UST	9.33e-04	161	79	4	C0269102
Disease	Endometriosis	NCOR1 VCAN CYP26A1 UST	9.33e-04	161	79	4	C0014175
Disease	Vitiligo	CD44 CLNK	9.38e-04	17	79	2	C0042900
Disease	Adenomatous Polyposis Coli	CYP26A1 CD44	9.38e-04	17	79	2	C0032580
Disease	hypothyroidism	DDX59 CD44 TMEM131 PPARG CLNK	1.01e-03	284	79	5	EFO_0004705
Disease	borna disease (biomarker_via_orthology)	CD44 EIF2A	1.05e-03	18	79	2	DOID:5154 (biomarker_via_orthology)
Disease	Corneal astigmatism	DHX15 DACT2 MADD	1.17e-03	77	79	3	EFO_1002040
Disease	thyroxine measurement	DHX15 NCOR1 PSMF1	1.45e-03	83	79	3	EFO_0005130
Disease	Giant Cell Glioblastoma	NCOR1 FAT1 PPARG	1.51e-03	84	79	3	C0334588
Disease	Pseudoaphakia	TDRD7 ATP2B1	1.88e-03	24	79	2	C0524524
Disease	Lens Opacities	TDRD7 ATP2B1	1.88e-03	24	79	2	C1510497
Disease	IGF-1 measurement	TRIM72 CCBE1 RC3H1 CYP26A1 PPARG TOP2A	1.99e-03	488	79	6	EFO_0004627
Disease	fasting blood glucose measurement, HOMA-B, fasting blood insulin measurement	CD44 MADD	2.04e-03	25	79	2	EFO_0004465, EFO_0004466, EFO_0004469
Disease	Adenoid Cystic Carcinoma	FAT1 VCAN TOP2A	2.48e-03	100	79	3	C0010606

Protein segments in the cluster

Peptide	Gene	Start	Entry
VFPSPEESEASPQVH	ABR	356	Q12979
HSPFRARSEPEDPVT	ALG1	241	Q9BT22
GEPDVFPTVPFHEEF	VCAN	1496	P13611
LPPERSDTPLHFNFF	FCRL4	216	Q96PJ5
VFDIPVFHPLVDPTS	AKTIP	141	Q9H8T0
VPEEPRAHSTARPFY	AJM1	361	C9J069
HQSSRFVFVPGPEDP	POLE2	356	P56282
THPVEIFYTPEPERD	DHX15	316	O43143
EVPEESPFPSHAQAT	DLGAP4	81	Q9Y2H0
EPIHGPPFDFSLESS	DSC2	601	Q02487
THPEFRIEDSEPHIP	ATP2B1	1146	P20020
VVSEEEFSRHIPPYP	ARRDC4	356	Q8NCT1
TLPPTFHPEEFLDED	RC3H1	781	Q5TC82
DEEFEPPAPFVTRFL	QSER1	1526	Q2KHR3
SAIPEHPEFSTFNPE	FAT1	4276	Q14517
EDHTEFPLPPDVVFF	MADD	41	Q8WXG6
DPSRFTLVDFPLHLP	MADD	286	Q8WXG6
VEFLPVYHPSPEESR	LPCAT4	266	Q643R3
SCPEDEPTSQHPFRI	MAPK4	316	P31152
RPFHTRATVDPDFPI	KIF26B	831	Q2KJY2
TIDRHISESCPFPSP	DDX59	51	Q5T1V6
FITPSFPTDGTHPFV	GRIA2	111	P42262
EEPRGDQPHSFFPES	FREM1	196	Q5H8C1
FLHASPPPCIEESFR	KLF7	61	O75840
PIEEFSPEFVEPRVS	LAMA5	1191	O15230
TETEPHVAFRPPASV	MEIS3P2	331	A8K0S8
APFTITPVFSDFPVH	NPC1	201	O15118
HRSRDTAEPSFPEIP	GASK1B	71	Q6UWH4
VLENPSPFHSPFRFE	ASF1B	11	Q9NVP2
EHIPESRPLSPTAFS	HAL	626	P42357
HSAECDPRFPSVIPE	DACT2	666	Q5SW24
YTFSTVHPIPDEDSP	CD44	196	P16070
THSSAEEFPLPQEFP	CCBE1	361	Q6UXH8
PLPVPLVTDFSHRED	CCDC78	336	A2IDD5
VIFLSTRDPTVEFPP	DYNC1H1	3676	Q14204
HEVPPPRSFTFLNDA	CUL9	2321	Q8IWT3
LPHPEDASRFSFIPF	CYP26A1	421	O43174
AFQPSILTEPPTEDH	ELP2	536	Q6IA86
PLFSEVSQRFPTTHP	FRY	1336	Q5TBA9
GPPHFTESTVFPRES	EIF2A	21	Q9BY44
PVFSTHDIPPVVSDE	CCDC192	276	P0DO97
PFPPTHRLTSEEVFD	PPP3CB	31	P16298
PVESLTAIPVFDPRH	CFAP74	1491	Q9C0B2
PFSPEEDPSRFRSLH	MFNG	291	O00587
VSSPHREFPPATARE	PSMF1	151	Q92530
FVPPSHVRFVFPEPT	PKD1	3056	P98161
PVSESAPLDSHFPLE	PCDHA12	141	Q9UN75
SEFHLRPPSDPETVY	MINDY2	491	Q8NBR6
RVPSDPFTGVAFTPH	UBOX5	301	O94941
FHSTDDPPRPTFDSL	TADA2A	146	O75478
SPERSHVSSEPYEPI	NCOR1	2136	O75376
PHYEDIPFTRTDPVV	PPARG	76	P37231
VDTDFPPLDSNEPIH	MAPKAP1	241	Q9BPZ7
VVRDFPAPLPESTVF	TBATA	101	Q96M53
DHTSAFSTEELPPPV	TDRD7	891	Q8NHU6
EERVSEAHRAFPPPS	TEX45	76	Q8NA69
RSPSFPLEPDDEVFL	TBC1D7	121	Q9P0N9
ESSRPPLSQRHTFPE	CLNK	181	Q7Z7G1
FRARPEALHSSPEDP	INPP5J	281	Q15735
APTFVPSVEAFDERP	TNRC18	371	O15417
ERSGPFTHPDFEPST	UBA3	46	Q8TBC4
HFFIPTPLETEEPID	UST	376	Q9Y2C2
VRHSSDPFYTPEPDT	TPH1	256	P17752
SEDAPCAVTFHPTRP	WDR90	741	Q96KV7
SHRPDSPALFTDIPT	SSH2	231	Q76I76
AFPHLSSEPRTPRAF	ARHGAP23	256	Q9P227
SDLERHPTPRLPFVD	TKTL2	106	Q9H0I9
HDSPALEVFTEQPPS	TMEM131	1361	Q92545
ASVLPPDTDPAFFEH	NAPRT	81	Q6XQN6
SLEEERTPTPVHYRP	MRPL28	31	Q13084
PALEELTFDPSSAHP	TRIM72	286	Q6ZMU5
PDPLPERSTFETEHA	YLPM1	1666	P49750
ATHFPDETEITNPVP	TOP2A	1396	P11388
PHEPSRPFASTFIDG	SEMA3G	171	Q9NS98
EHPSVPESPEFVRVR	STARD7	251	Q9NQZ5
RPVETDSESEFPVFP	ARHGAP21	1631	Q5T5U3
VEEEPEFSLPQPSLH	ZFC3H1	1001	O60293
IECPSSPSFPRDISH	ZNF106	6	Q9H2Y7
FVIRHVDPPSPRADT	SPATA6	256	Q9NWH7
EPRTEFQPSFPHLVA	ZNF169	86	Q14929
TEHPPPGIFNSELEF	LDLRAD4	51	O15165
MSFVLEEPREFPPHS	NLRP13	546	Q86W25